Drug Development market research reports by DelveInsight

• PD-1 and PD-L1 Inhibitors - Competitive landscape, 2024

  Dec 01, 2024  |  Published by: DelveInsight  |  USD 5,000

  PD-1 and PD-L1 Inhibitors - Competitive landscape, 2024 DelveInsight’s, “PD-1 and PD-L1 Inhibitors - Competitive landscape, 2024,” report provides comprehensive insights about 180+ companies and 200+ drugs in PD-1 and PD-L1 Inhibitors Competitive landscape. It covers the therapeutics assessment by ... Read More

• Parkinson's Disease Psychosis Market Insight, Epidemiology And Market Forecast - 2034

  Sep 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Parkinson's Disease Psychosis Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights In 2023, the market size of Mild Cognitive Impairment (MCI) was highest in the US among the 7MM, accounting for approximately USD 1,467 million which is further expected to increase by 2034. In 2023, ... Read More

• Artificial Intelligence (AI) In Drug Discovery - Market Insight, Competitive Landscape And Market Forecast - 2030

  Jul 01, 2024  |  Published by: DelveInsight  |  USD 3,750

  Artificial Intelligence (AI) In Drug Discovery - Market Insight, Competitive Landscape And Market Forecast - 2030 Artificial Intelligence (AI) in Drug Discovery Market by Type (De Novo Drugs Design and Optimization, Preclinical Testing, and Others), Application (Oncology, Cardiovascular, Infection D ... Read More

• Global Messenger RNA – Market Insight, Epidemiology, and Market Forecast – 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Global Messenger RNA – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Global Messenger RNA – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Global Messenger RNA, historical and forecasted epidemiology as well as ... Read More

• 20s Proteasome Inhibitor - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  20s Proteasome Inhibitor - Pipeline Insight, 2024 “20s Proteasome Inhibitor - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 20s Proteasome Inhibitor development. The report provides d ... Read More

• Acute Lymphoblastic Leukemia (ALL) - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Acute Lymphoblastic Leukemia (ALL) - Pipeline Insight, 2024 Acute Lymphoblastic Leukemia (ALL) Overview ""Acute Lymphoblastic Leukemia (ALL) Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Acute L ... Read More

• G-Protein Coupled Receptor (GPCR) Agonist - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  G-Protein Coupled Receptor (GPCR) Agonist - Pipeline Insight, 2024 “G-Protein Coupled Receptor (GPCR) Agonist - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across G-Protein Coupled Recepto ... Read More

• GPCR-Targeting Therapies - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  GPCR-Targeting Therapies - Pipeline Insight, 2024 GPCR-Targeting Therapies Overview ""GPCR-Targeting Therapies Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the GPCR-Targeting Therapies market. A de ... Read More

• GNE Myopathy - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  GNE Myopathy - Pipeline Insight, 2024 GNE Myopathy Overview ""GNE Myopathy Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the GNE Myopathy market. A detailed picture of the GNE Myopathy pipeline land ... Read More

• GLIOVAC Emerging Drug Insight and Market Forecast − 2032

  Nov 01, 2023  |  Published by: DelveInsight  |  USD 3,250

  GLIOVAC Emerging Drug Insight and Market Forecast − 2032 “GLIOVAC Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about GLIOVAC for glioblastoma multiforme (GBM) in the seven major markets. A detailed picture of the GLIOVAC for GBM in the 7MM, i.e., the Unite ... Read More

• RNA Interference Therapy-Competitive landscape, 2023

  May 01, 2023  |  Published by: DelveInsight  |  USD 3,500

  RNA Interference Therapy-Competitive landscape, 2023 DelveInsight’s, “RNA Interference Therapy - Competitive landscape, 2023,” report provides comprehensive insights about 40+ companies and 90+ drugs in RNA Interference Therapy Competitive landscape. It covers the therapeutics assessment by product ... Read More

• COVID-19- Competitive Landscape, 2023

  Apr 01, 2023  |  Published by: DelveInsight  |  USD 3,250

  COVID-19- Competitive Landscape, 2023 DelveInsight’s, “COVID-19 - Competitive landscape, 2023,” report provides comprehensive insights about 400+ companies and 500+ drugs in COVID-19 Competitive landscape. It covers the therapeutics assessment by product type, stage, route of administration, and mol ... Read More

• Phosphatidylinositol 3-Kinase (PI3K) Inhibitors- Pipeline Insight, 2023

  Mar 01, 2023  |  Published by: DelveInsight  |  USD 2,000

  Phosphatidylinositol 3-Kinase (PI3K) Inhibitors- Pipeline Insight, 2023 DelveInsight’s, “Phosphatidylinositol 3-Kinase (PI3K) Inhibitors- Pipeline Insight, 2023” report provides comprehensive insights about 22+ companies and 24+ pipeline drugs in Phosphatidylinositol 3-Kinase (PI3K) Inhibitors pipel ... Read More

• Drug Discovery - Market Insights, Competitive Landscape, and Market Forecast - 2027

  Feb 01, 2023  |  Published by: DelveInsight  |  USD 2,750

  Drug Discovery - Market Insights, Competitive Landscape, and Market Forecast - 2027 Drug Discovery Market By Workflow (Target Identification & Screening, Target Validation & Functional Informatics, Lead Identification & Candidate Optimization, Preclinical Development, And Others), By Drug Type (Smal ... Read More

• Polycythemia Vera Market Insight, Epidemiology and Market Forecast -2032

  Jan 01, 2023  |  Published by: DelveInsight  |  USD 7,500

  Polycythemia Vera Market Insight, Epidemiology and Market Forecast -2032 Key Highlights: In 2022, the market size of Polycythemia Vera was highest in the US among the 7MM accounting for approximately USD 1,500 million that is further expected to increase by 2032 PharmaEssentia’s Besremi is the only ... Read More

• HUMIRA Market Drug Insight and Market Forecast − 2032

  Dec 01, 2022  |  Published by: DelveInsight  |  USD 2,750

  HUMIRA Market Drug Insight and Market Forecast − 2032 “HUMIRA Market Drug Insight and Market Forecast – 2032” report provides comprehensive insights about HUMIRA for Ulcerative Colitis (UC) in the seven major markets. A detailed picture of the HUMIRA for ulcerative colitis in the 7MM, i.e., United S ... Read More

• COVID-19- Competitive Landscape, 2022

  Oct 01, 2022  |  Published by: DelveInsight  |  USD 4,950

  COVID-19- Competitive Landscape, 2022 DelveInsight’s, “COVID-19- Competitive landscape, 2022,” report provides comprehensive insights about 420+ companies and 520+ drugs in Covid-19 Competitive landscape. It covers the therapeutics assessment by product type, stage, route of administration, and mole ... Read More

• TIGIT Inhibitors - Competitive Landscape, 2022

  Oct 01, 2022  |  Published by: DelveInsight  |  USD 2,500

  TIGIT Inhibitors - Competitive Landscape, 2022 DelveInsight’s, “TIGIT inhibitors - Competitive landscape, 2022,” report provides comprehensive insights about 18+ companies and 20+ drugs in TIGIT inhibitors Competitive landscape. It covers the therapeutics assessment by product type, stage, route of ... Read More

• TIGIT Inhibitors - Competitive Landscape, 2022

  Oct 01, 2022  |  Published by: DelveInsight  |  USD 2,500

  TIGIT Inhibitors - Competitive Landscape, 2022 DelveInsight’s, “TIGIT inhibitors - Competitive landscape, 2022,” report provides comprehensive insights about 18+ companies and 20+ drugs in TIGIT inhibitors Competitive landscape. It covers the therapeutics assessment by product type, stage, route of ... Read More

• RNA- Competitive Landscape, 2022

  Oct 01, 2022  |  Published by: DelveInsight  |  USD 2,950

  RNA- Competitive Landscape, 2022 DelveInsight’s, “RNA- Competitive landscape, 2022,” report provides comprehensive insights about 85+ companies and 100+ drugs in RNA Competitive landscape. It covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It fu ... Read More

• Janus kinase (JAK) Inhibitors- Competitive Landscape, 2022

  Oct 01, 2022  |  Published by: DelveInsight  |  USD 2,950

  Janus kinase (JAK) Inhibitors- Competitive Landscape, 2022 DelveInsight’s, “Janus kinase (JAK) inhibitors- Competitive landscape, 2022,” report provides comprehensive insights about 40+ companies and 45+ drugs in Janus kinase (JAK) inhibitors Competitive landscape. It covers the therapeutics ass ... Read More

• PD-1 and PD-L1 Inhibitors- Competitive Landscape, 2022

  Oct 01, 2022  |  Published by: DelveInsight  |  USD 3,950

  PD-1 and PD-L1 Inhibitors- Competitive Landscape, 2022 DelveInsight’s, “PD-1 AND PD-L1 Inhibitors- Competitive landscape, 2022,” report provides comprehensive insights about 180+ companies and 200+ drugs in PD-1 and PD-L1 Inhibitors Competitive landscape. It covers the therapeutics assessment by pr ... Read More

• PCSK9 Inhibitors - Market Insight, Epidemiology and Market Forecast – 2032

  Sep 01, 2022  |  Published by: DelveInsight  |  USD 7,500

  PCSK9 Inhibitors - Market Insight, Epidemiology and Market Forecast – 2032 DelveInsight's "" PCSK9 Inhibitors (PCSK9i)- Market Insight, Epidemiology and Market Forecast-2032"" report delivers an in-depth understanding of PCSK9i, historical and forecasted epidemiology as well as the PCSK9i trends in ... Read More

• iPSC derived NK cells - Pipeline Insight, 2022

  Mar 01, 2022  |  Published by: DelveInsight  |  USD 2,000

  DelveInsight’s, “ IPSCs derived NK cells – Pipeline Insight, 2021 ,” report provides comprehensive insights about 15+ companies and 30+ pipeline drugs in IPSCs derived NK cells pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers ... Read More

• Global Messenger RNA - Epidemiology Forecast - 2032

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 3,950

  DelveInsight's "" Global Messenger RNA - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Global Messenger RNA epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japa ... Read More

< prev 1 2 next >